Amgen Inc (USD)
AMGN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range248.10 | 251.42
52-Wk Range- | -
Last Close248.30
Mkt Cap (m)145,427.76
Dividend yield2.52
ISINUS0311621009
Volume194,025.00
Exchange VenueNAS

Company Profile

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

Key Information
Price/Earning20.27
Price/Book13.64
Price/Sales6.09
P/CF13.63
Rev Growth (3 year avg)0.54
EPS Growth (3 year avg)0.08
Operating Margin % 41.41
Net Margin %33.57
Return on Equity70.73
Debt/Equity3.09

Documents

Prospectus
en 06/05/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.amgen.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)20,063.0021,662.0022,991.0022,849.0023,747.0023,362.00
Operating Income (m)6,191.008,470.009,794.009,973.0010,263.009,674.00
Net Income (m)5,158.006,939.007,722.001,979.008,394.007,842.00
Basic EPS6.809.1510.322.7112.7012.96
Avg. Diluted Shares Outstanding (m)770.00766.00754.00735.00665.00609.00
Balance Sheet
USD201420152016201720182019
Current Assets (m)34,713.0038,518.0046,010.0049,476.0037,618.0018,440.00
Non Current Assets (m)34,296.0033,058.0031,616.0030,478.0028,798.0041,267.00
Total Assets (m)69,009.0071,576.0077,626.0079,954.0066,416.0059,707.00
Current Liabilities (m)7,008.008,667.0011,204.009,020.0013,488.0012,835.00
Total Liabilities (m)------
Total Equity (m)25,778.0028,083.0029,875.0025,241.0012,500.009,673.00
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)8,555.009,077.0010,354.0011,177.0011,296.009,150.00
Capital Expenditure (m)-1,003.00-649.00-837.00-664.00-738.00-618.00
Figures are quoted in USD unless stated otherwise
2.82 (1.14%)
$
251.12
Last Price